 |
PDBsum entry 1jma
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Viral protein
|
PDB id
|
|
|
|
1jma
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Herpes simplex virus glycoprotein d bound to the human receptor hvea.
|
 |
|
Authors
|
 |
A.Carfí,
S.H.Willis,
J.C.Whitbeck,
C.Krummenacher,
G.H.Cohen,
R.J.Eisenberg,
D.C.Wiley.
|
 |
|
Ref.
|
 |
Mol Cell, 2001,
8,
169-179.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Herpes simplex virus (HSV) infection requires binding of the viral envelope
glycoprotein D (gD) to cell surface receptors. We report the X-ray structures of
a soluble, truncated ectodomain of gD both alone and in complex with the
ectodomain of its cellular receptor HveA. Two bound anions suggest possible
binding sites for another gD receptor, a 3-O-sulfonated heparan sulfate.
Unexpectedly, the structures reveal a V-like immunoglobulin (Ig) fold at the
core of gD that is closely related to cellular adhesion molecules and flanked by
large N- and C-terminal extensions. The receptor binding segment of gD, an
N-terminal hairpin, appears conformationally flexible, suggesting that a
conformational change accompanying binding might be part of the viral entry
mechanism.
|
 |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. The gD-HveA Interface
|
 |
Figure 5.
Figure 5. Conformational Change in the N
Terminus of gD
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2001,
8,
169-179)
copyright 2001.
|
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
Herpes simplex virus-1 entry into cells mediated by a novel member of the tnf/ngf receptor family.
|
 |
|
Authors
|
 |
R.I.Montgomery,
M.S.Warner,
B.J.Lum,
P.G.Spear.
|
 |
|
Ref.
|
 |
Cell, 1996,
87,
427-436.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Southern and Northern Blots for Detection of
HVEM–Homologous DNA and RNA in Cells and Tissues(A–C) Cell
DNAs were extracted and digested with BamHI and the fragments
separated by electrophoresis and transferred to Duralon nylon
membrane for hybridization. The DNAs were from HeLa (lanes 2),
HEp-2 (lanes 3), CHO-K1 (lanes 4), CHO-HVEM12 (lanes 5), and
Vero (lanes 6) cells. BamHI-digested plasmid, pBEC580, was also
included (lanes 7).(A) Photograph of the ethidium
bromide–stained gel.(B) Autoradiogram of the blot using the
PvuII probe indicated in (D).(C) Autoradiogram of the blot using
the EcoRI probe indicated in (D).(D) Schematic diagram of the
HVEM cDNA and fragments used to generate probes. Numbers on the
left of (A) and bands in lane 1 indicate molecular size markers
(kbp).(E) A Northern blot (Clontech) of polyadenylated RNAs
extracted from various human tissues and hybridized with a
^32P-labeled probe from the PvuII fragment indicated in (D). The
RNAs were extracted from heart (lane 1), brain (lane 2),
placenta (lane 3), lung (lane 4), liver (lane 5), skeletal
muscle (lane 6), kidney (lane 7), and pancreas (lane 8). Amounts
on the blot were normalized with respect to actin mRNA content.
|
 |
Figure 5.
Figure 5. Enhanced Entry of HSV-1(KOS) into
HVEM–Expressing Cell Lines and Inhibition of Infection by
Anti–HVEM Antibodies or HVEM:Fc(A) Several HVEM–expressing
and control cell lines were obtained by transfection of CHO-K1
cells or ST cells with pBEC10 or control plasmid pcDNA3,
followed by selection for stable maintenance of the plasmid.
Representative clones were plated in 96 well plates and exposed
to KOS-gL86 at the doses indicated. Later (6 hr), viral entry
was quantitated as described in the legend to Figure 1.
CHO-HVEM11 and ST-HVEM1 (open circles), CHO-HVEM9 and ST-HVEM22
(closed circles), and CHO-HVEM12 and ST-HVEM2 (open squares)
were isolated after transfection with the HVEM–expressing
plasmid pBEC10. CHO-C8 and ST-C8 (closed squares) were
isolated after transfection with the control plasmid pcDNA3.(B
and C) CHO-HVEM12 cells or ST-HVEM1 cells were plated in 96 well
dishes. In (B), the cells were exposed to preimmune or immune
rabbit serum at the dilutions indicated for 30 min at 37°C.
Various amounts of KOS-gL86 were then added in one-fifth volume,
and incubation continued for 2 hr. In (C), virus was mixed with
various concentrations of HVEM:Fc or normal rabbit IgG and
incubated for 30 min at 37°C. The mixtures (50 μl) were
added to washed cells, and incubation continued for 2 hr. The
virus–serum or virus–HVEM:Fc mixtures were then removed and
the cells exposed briefly to low pH buffer to inactivate
residual extracellular virus. The cells were washed and
incubated for an additional 4 hr before lysis and addition of
ONPG. The amount of virus added was 10^7 pfu/well in (B) and
10^6 pfu/well in (C). Open symbols were preimmune serum (B) or
normal rabbit IgG (C). Closed symbols were immune serum (B) or
HVEM:Fc (C).
|
 |
|
 |
 |
|
The above figures are
reproduced from the cited reference
with permission from Cell Press
|
 |
|
|
|
|
 |